Related Experiment Video
Updated: Jul 28, 2026
07:42
Imaging of Estrogen Receptor-α in Rat Pial Arterioles using a Digital Immunofluorescent Microscope
Published on: November 29, 2011
Estrogens and atherosclerosis: phytoestrogens and selective estrogen receptor modulators
1Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA. rstclair@wfubmc.edu
Current Opinion in Lipidology
|November 13, 1998
Summary
Estrogen therapy significantly reduces atherosclerosis and heart disease in postmenopausal women. Plant-derived phytoestrogens also show promise for cardiovascular health, similar to novel designer hormones.
Area of Science:
- Cardiovascular Science
- Endocrinology
- Nutritional Science
Background:
- Estrogen therapy demonstrates protective effects against atherosclerosis in animal models and coronary heart disease in postmenopausal women.
- Estrogen exerts both acute vascular reactivity improvements and long-term benefits in atherosclerosis pathogenesis.
- Phytoestrogens from plant sources, while weaker estrogens, exhibit significant positive impacts on arterial health.
Purpose of the Study:
- To review the cardiovascular benefits of estrogen and phytoestrogens.
- To explore the mechanisms underlying estrogen's protective effects on the vascular system.
- To compare the potential of phytoestrogens and designer hormones for cardiovascular and skeletal health.
Main Methods:
- Literature review of studies on estrogen therapy and atherosclerosis.
- Analysis of research on phytoestrogens in plant-based foods.
- Comparison of phytoestrogens with synthetic 'designer hormones'.
Main Results:
- Estrogen treatment markedly reduces atherosclerosis development and coronary heart disease incidence.
- Phytoestrogens show potent beneficial effects on the arterial wall.
- Phytoestrogens share similarities with designer hormones aimed at cardiovascular and skeletal benefits without adverse effects.
Conclusions:
- Estrogen therapy is effective in mitigating cardiovascular disease.
- Phytoestrogens represent a promising natural alternative for cardiovascular protection.
- Designer hormones and phytoestrogens offer potential therapeutic strategies for cardiovascular and skeletal health.
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:31Transducer Mechanism: Nuclear Receptors
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
01:25Dose-Response Relationship: Selectivity and Specificity
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...